Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03144531
Other study ID # STUDY00001834
Secondary ID P30NR016585-01
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2017
Est. completion date August 8, 2018

Study information

Verified date July 2021
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Behavioral intervention for 6-11 year children with persistent asthma and sleep disturbance and a parent with sleep disturbance.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date August 8, 2018
Est. primary completion date July 30, 2018
Accepts healthy volunteers No
Gender All
Age group 6 Years to 11 Years
Eligibility Inclusion Criteria (child): - Children 6-11 years - Child diagnosis of asthma with prescription for daily medication - Able to understand English (child) - Sleep disturbance per CSHQ (child >= 41) and/or < 9 hours of sleep per night Exclusion Criteria (child) - Parent reported diagnosis of traumatic brain injury, developmental delay, autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), obstructive sleep apnea, cancer - Positive sleep related breathing disorder screening (obstructive sleep apnea screening) Inclusion Criteria (parent) - 18 years or older - Able to understand and read English - Lives with child 50% of time or more - Is child's legal guardian - Has reliable access to internet - >/= 5 on Pittsburgh Sleep Quality Index or <7 hours overnight reported sleep Exclusion Criteria (parent) - Diagnosed obstructive sleep apnea or sleep disordered breathing - Is a nightshift worker - Uses sleep medication

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Sleep Intervention for Kids and Parents (SKIP)
Dyadic approach using self-efficacy theory to set goals, anticipate barriers, problem solve

Locations

Country Name City State
United States University of Washington School of Nursing Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
University of Washington National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total sleep time Actigraphy 3 months post intervention (x 10 days of measurement)
Primary Sleep efficiency Actigraphy 3 months post intervention (x 10 days of measurement)
Primary Bedtime Consistency Actigraphy 3 months post intervention (x 10 days of measurement)
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device